Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study
- PMID: 19254985
- DOI: 10.1542/peds.2008-0581
Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study
Abstract
Objective: We examined the physical, cognitive, educational, social, and psychological outcomes of invasive meningococcal disease in adolescence, as well as demographic and disease factors associated with outcomes.
Methods: A population-based, matched-cohort study was performed. A total of 101 gender- and age-matched case-control pairs (15-19 years of age at the time of disease; 46% male) from 6 regions of England underwent follow-up evaluations 18 to 36 months after invasive meningococcal disease. Educational, social, and vocational function, mental health, social support, self-efficacy, and quality-of-life data were collected by using standardized questionnaires and neuropsychological tests.
Results: Fifty-seven percent of case subjects (n = 58) had major physical sequelae. Survivors had greater depressive symptoms, greater fatigue, less social support, greater reduction in quality of life, and lower educational attainment compared with control subjects. Survivors with serogroup C disease had greater physical sequelae than did those with serogroup B disease. Greater cognitive deficits were associated with younger age at diagnosis. Only 53 of 101 case subjects reported any medical follow-up care after invasive meningococcal disease.
Conclusions: Survivors of invasive meningococcal disease in adolescence have a disturbing series of deficits, including poorer physical and mental health, quality of life, and educational achievement. Serogroup C is associated with poorer outcomes. Invasive meningococcal disease attributable to serogroup B disease remains a major cause of morbidity and death among adolescents. Medical care is poor after discharge from the hospital. Routine follow-up care of adolescent survivors may prevent or ameliorate physical and psychosocial morbidity after invasive meningococcal disease.
Similar articles
-
Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study.Lancet Neurol. 2012 Sep;11(9):774-83. doi: 10.1016/S1474-4422(12)70180-1. Epub 2012 Aug 3. Lancet Neurol. 2012. PMID: 22863608
-
An explorative study on quality of life and psychological and cognitive function in pediatric survivors of septic shock.Pediatr Crit Care Med. 2009 Nov;10(6):636-42. doi: 10.1097/PCC.0b013e3181ae5c1a. Pediatr Crit Care Med. 2009. PMID: 19581821
-
The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.Patient Educ Couns. 2007 Apr;66(1):108-18. doi: 10.1016/j.pec.2006.11.005. Epub 2007 Feb 21. Patient Educ Couns. 2007. PMID: 17320337
-
Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.Expert Rev Vaccines. 2009 May;8(5):529-42. doi: 10.1586/erv.09.18. Expert Rev Vaccines. 2009. PMID: 19397410 Review.
-
Expanding prevention of invasive meningococcal disease.Expert Rev Vaccines. 2009 Jun;8(6):717-27. doi: 10.1586/erv.09.37. Expert Rev Vaccines. 2009. PMID: 19485753 Review.
Cited by
-
[Health Technology Assessment (HTA) of the introduction of additional cohorts for anti-meningococcal vaccination with quadrivalent conjugate vaccines in Italy].J Prev Med Hyg. 2021 May 13;62(1 Suppl 1):E1-E128. doi: 10.15167/2421-4248/jpmh2021.62.1s1. eCollection 2021 Mar. J Prev Med Hyg. 2021. PMID: 34622076 Free PMC article. Italian. No abstract available.
-
The health, social and educational needs of children who have survived meningitis and septicaemia: the parents' perspective.BMC Public Health. 2013 Oct 10;13:954. doi: 10.1186/1471-2458-13-954. BMC Public Health. 2013. PMID: 24112360 Free PMC article.
-
Chemoprophylaxis and vaccination in preventing subsequent cases of meningococcal disease in household contacts of a case of meningococcal disease: a systematic review.Epidemiol Infect. 2015 Aug;143(11):2259-68. doi: 10.1017/S0950268815000849. Epub 2015 Apr 28. Epidemiol Infect. 2015. PMID: 25916733 Free PMC article.
-
Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy.J Prev Med Hyg. 2020 Jul 4;61(2):E152-E161. doi: 10.15167/2421-4248/jpmh2020.61.2.1589. eCollection 2020 Jun. J Prev Med Hyg. 2020. PMID: 32802999 Free PMC article.
-
Invasive meningococcal disease in the 21st century—an update for the clinician.Curr Neurol Neurosci Rep. 2015 Mar;15(3):2. doi: 10.1007/s11910-015-0524-6. Curr Neurol Neurosci Rep. 2015. PMID: 25637287 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources